News

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

Titan Medical Inc. (the "Company") (TSX VENTURE:TMD) announced today that the 4,880,000 warrants issued as part of its offering of units completed on December 22, 2011 were listed to commence trading on the TSX Venture Exchange on January 23, 2012. The warrants, designated as December 2016 Warrants, will trade under the symbol "TMD.WT.B" and bear the CUSIP number, 88830X 132.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

Titan Medical Inc. (the "Company") (TSX VENTURE:TMD) announced today that it has closed its previously announced offering of securities made pursuant to an agency agreement dated December 19, 2011 between the Company and Kingsdale Capital Markets Inc. The Company sold 4,880,000 units at a price of $1.55 each for gross proceeds of $7,564,000. Each unit comprises one common share of the Company and one common share purchase warrant of the Company. Each warrant entitles the holder thereof to purchase one additional common share of the Company for $1.75 until December 22, 2016.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

Titan Medical Inc. (TSX VENTURE:TMD) (the "Company") announced today that it has filed a prospectus supplement (the "Prospectus Supplement") dated December 19, 2011 with securities regulators in respect of its previously announced offering of securities (the "Offering"). The Offering consists of a maximum of 4,516,129 units ("Units") which will be offered at $1.55 each (the "Offering Price"), for gross proceeds of up to $7,000,000. Each Unit will consist of one common share and one warrant. Each whole warrant will entitle the holder to purchase one additional common share for $1.75 during a term of 60 months following closing of the Offering.

TORONTO, ONTARIO--(Marketwire - Dec. 16, 2011) - Titan Medical Inc. (TSX VENTURE:TMD) -

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States.

The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Titan Medical Inc. (the "Company") (TSX VENTURE:TMD) announces that it has increased its previously announced financing, led by Kingsdale Capital Markets Inc. ("Kingsdale"), to up to 4,516,129 units (the "Units") at a price (the "Issue Price") of $1.55 per Unit for gross proceeds of up to $7,000,000 (the "Offering"). Each Unit shall consist of one common share of the Company and one common share purchase warrant (a "Warrant"), with each whole Warrant entitling the holder thereof to acquire one common share of the Company at $1.75 for 5 years following closing of the Offering.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

Titan Medical Inc. (the "Company") (TSX VENTURE:TMD) announced today that it has entered into an agreement with Kingsdale Capital Markets Inc. ("Kingsdale") for an overnight marketed offering of up to 3,225,807 units (the "Units") from treasury of the Company at a price (the "Issue Price") of $1.55 per Unit for gross proceeds of up to $5,000,000 (the "Offering"). Each Unit shall consist of one common share of the Company and one common share purchase warrant (a "Warrant"), with each whole Warrant entitling the holder thereof to purchase one common share of the Company at $1.75 for 5 years following closing of the Offering.

TORONTO, ONTARIO--(Marketwire - Dec. 5, 2011) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) announced today that it has signed a non-binding memorandum of understanding (MOU) with Apollo Hospitals Enterprise Limited ("Apollo"), a major hospital chain based in Chennai, India.

TORONTO, ONTARIO--(Marketwire - Nov. 15, 2011) - Titan Medical Inc. ("Titan" or the "Company") (TSX VENTURE:TMD) announced today results for the three and nine months ended September 30, 2011.

TORONTO, ONTARIO--(Marketwire - Oct. 5, 2011) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) announced today that it has signed a non-binding memorandum of understanding (MOU) with Children's Hospital Boston.

TORONTO, ONTARIO--(Marketwire - Sept. 28, 2011) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) announced today that it has signed a non-binding memorandum of understanding (MOU) with The Ohio State University ("Ohio State").